flyExclusive Reaffirms Strategic Priorities and Provides Update on Pending Jet.AI Transaction

Stock Information for Y-mAbs Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Y-mAbs Therapeutics Inc.

Jet.AI Within 2.1% (29,594 Shares) of Securing Shareholder Approval for Proposed flyExclusive Transaction; Meeting Adjourned Until July 2
Jet.AI Issues Investor Guide on Proposed flyExclusive Merger Transaction
Jet.AI Announces New Record Date for Distribution of SpinCo Shares in Connection with Proposed flyExclusive Transaction
Jet.AI Announces Adjournment of Previously Scheduled Special Meeting of Stockholders
Jet.AI to Present in Maxim Group's "Architecting Tomorrow: The AI Data Center Summit" on Thursday, June 11, 2026 at 1:30 p.m. ET
Jet.AI Announces Review of Strategic Alternatives for SpaceX Equity Interest
JET.AI ANNOUNCES LEADING INDEPENDENT PROXY ADVISORY FIRM ISS RECOMMENDS STOCKHOLDERS VOTE "FOR" THE PROPOSED MERGER
Jet.AI Announces Record Date for Distribution of SpinCo Shares in Connection with Proposed flyExclusive Transaction

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.